Triterpenoid derivatives for the treatment of cancer and pharmaceutical compositions containing these derivatives
Abstract
Triterpenoid derivatives derived from penta-and tetracylic triterpenoids of general formula also for treating cancer, especially leukemia and cancers of lung carcinoma and breast carcinoma,pharmaceutical compositions intended for the treatment of cancer, especially for treatment of leukemic disease and lung and breast cancers, including those derivatives, preferably inclusion in the form of cyclodextrin.